These data imply that in IL-7-dependent T-ALL cell line TAIL7, preventing a specific substrate(p27) degradation might exert stronger inhibitor effects than inhibition of Skp2 function by disrupting the SCFSkp2 complex. Here, CDKN1B is linked to acute lymphoblastic leukemia.